In addition to treating fatty liver disease, oxidative damage in autoimmune disease and autism, respiratory disease, and other serious medical conditions, many clinics nowadays offer glutathione IV therapy as an antioxidant boost without the need of prescription or a serious diagnosis
However, a drawback of these medicines has been the necessity for administration by subcutaneous injection, which limits patient utilization and may reduce opportunities for fixed-dose combination treatments with other small-molecule drugs
Is it due to the medication alone
Xue X, Ren Z, Zhang A, Yang Q, Zhang W, Liu F (2016) Efficacy and safety of once-weekly glucagon-like peptide-1 receptor agonists compared with exenatide and liraglutide in type 2 diabetes: a systemic review of randomised controlled trials
UK Comparison Guide Meta Description (158 chars): TB-500 or BPC-157 for injury healing